Victoza
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Results from a recent ELLIPSE trial indicate superiority in reducing blood sugar when compared to the placebo.
Victoza (liraglutide) is a modern antidiabetic drug of GLP1 (glucagone like peptide) analogue group; since 2009 registered in…
Le diabete et son suivi representent un enjeu majeur en termes de sante publique. En effet, plus de 3 millions de personnes en…
Background: The incidence of obesity is increasing dramatically to epidemic proportions. There are few approved anti-obesity…
Adipositas und Diabetes sind zwei haufige metabolische Krankheiten, die beide normaler-weise mit einem erhohten inflammatorischen…
Novo Nordisk recently sent a letter to healthcare professionals, reminding them about the potential risks of thyroid C-Cell…
New molecular entity: Liraglutide (Victoza) was approved January 25, 2010 to improve blood sugar control in adults with type 2…
NEW DRUGS Victoza Is a New Contender In the Diabetes Arena A drug that helps the pancreas make more insulin has been approved…